In agreement with the data in the Lund and London cohorts, the levels of blood NfL were increased in PSP (p < 0.001), MSA (p < 0.001), and CBS (p < 0.001) compared to patients with PD already early in the disease (figure 2C). This evidence concerns the gene CBS and Parkinson disease.